Invention Grant
- Patent Title: Human anti-PD-1 antibodies and uses therefor
- Patent Title (中): 人抗PD-1抗体及其用途
-
Application No.: US13802172Application Date: 2013-03-13
-
Publication No.: US09102727B2Publication Date: 2015-08-11
- Inventor: Gordon J. Freeman , Rafi Ahmed , Timothy D. Jones , Francis J. Carr , James P. Gregson
- Applicant: DANA-FARBER CANCER INSTITUTE, INC. , Emory University
- Applicant Address: US GA Atlanta US MA Boston
- Assignee: EMORY UNIVERSITY,DANA-FARBER CANCER INSTITUTE, INC.
- Current Assignee: EMORY UNIVERSITY,DANA-FARBER CANCER INSTITUTE, INC.
- Current Assignee Address: US GA Atlanta US MA Boston
- Agency: Morrison & Foerster LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C12N5/10 ; C12P21/08 ; C07H21/00 ; A61K39/00
Abstract:
The present invention is based, in part, on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. Accordingly, the invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-L1, and/or PD-L2 activity (e.g., persistent infectious diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders and tumors) using the novel human anti-PD-1, PD-L1, and PD-L2 antibodies described herein.
Public/Granted literature
- US20130291136A1 HUMAN ANTI-PD-1, PD-L1, AND PD-L2 ANTIBODIES AND USES THEREFOR Public/Granted day:2013-10-31
Information query
